Literature DB >> 29890391

Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway.

Justine Renaud1, Valentina Bassareo2, Jimmy Beaulieu1, Annalisa Pinna3, Michele Schlich4, Carole Lavoie5, Daniela Murtas6, Nicola Simola2, Maria-Grazia Martinoli7.   

Abstract

Epidemiological evidence suggests a correlation between diabetes and age-related neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Hyperglycemia causes oxidative stress in vulnerable tissues such as the brain. We recently demonstrated that elevated levels of glucose lead to the death of dopaminergic neurons in culture through oxidative mechanisms. Considering the lack of literature addressing dopaminergic alterations in diabetes with age, the goal of this study was to characterize the state of 2 critical dopaminergic pathways in the nicotinamide-streptozotocin rat model of long-term hyperglycemia, specifically the nigrostriatal motor pathway and the reward-associated mesocorticolimbic pathway. Neuronal and glial alterations were evaluated 3 and 6 months after hyperglycemia induction, demonstrating preferential degeneration of the nigrostriatal pathway complemented by a noticeable astrogliosis and loss of microglial cells throughout aging. Behavioral tests confirmed the existence of motor impairments in hyperglycemic rats that resemble early parkinsonian symptomatology in rats, pensuing from nigrostriatal alterations. These results solidify the relation between hyperglycemia and nigrostriatal dopaminergic neurodegeneration, providing new insight on the higher occurrence of Parkinson's disease in diabetic patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocyte; Dopamine; Dorsal striatum; Hyperglycemia; Microglia; Nicotinamide-streptozotocin model; Substantia nigra pars compacta

Mesh:

Year:  2018        PMID: 29890391     DOI: 10.1016/j.neurobiolaging.2018.05.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Metabolism and memory: α-synuclein level in children with obesity and children with type 1 diabetes; relation to glucotoxicity, lipotoxicity and executive functions.

Authors:  Nouran Yousef Salah; Sara Ibrahim Taha; Safeya Hassan; Mai Seif ElDin Abdeen; Mostafa Ahmad Hashim; Rana Mahmoud
Journal:  Int J Obes (Lond)       Date:  2022-09-24       Impact factor: 5.551

2.  Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways.

Authors:  Prachya Kongtawelert; Chayanut Kaewmool; Thanyaluck Phitak; Mattabhorn Phimphilai; Peraphan Pothacharoen; Thuzar Hla Shwe
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

3.  Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction.

Authors:  Shizhan Ma; Wenkai Bi; Xueying Liu; Shangbin Li; Yaxin Qiu; Chengcheng Huang; Renjun Lv; Qingqing Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-01       Impact factor: 6.055

Review 4.  Glycolytic metabolism supports microglia training during age-related neurodegeneration.

Authors:  Alberto Camacho-Morales
Journal:  Pharmacol Rep       Date:  2022-04-03       Impact factor: 3.919

5.  Hydrogen Sulfide Inhibits High Glucose-Induced Neuronal Senescence by Improving Autophagic Flux via Up-regulation of SIRT1.

Authors:  Lei Wu; Ying Chen; Chun-Yan Wang; Yi-Yun Tang; Hong-Lin Huang; Xuan Kang; Xiang Li; Yu-Rong Xie; Xiao-Qing Tang
Journal:  Front Mol Neurosci       Date:  2019-08-20       Impact factor: 5.639

Review 6.  Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.

Authors:  Fauze Camargo Maluf; David Feder; Alzira Alves de Siqueira Carvalho
Journal:  Parkinsons Dis       Date:  2019-11-23

7.  Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.

Authors:  Iara Pérez-Taboada; Samuel Alberquilla; Eduardo D Martín; Rishi Anand; Stefania Vietti-Michelina; Nchimunya N Tebeka; James Cantley; Stephanie J Cragg; Rosario Moratalla; Mario Vallejo
Journal:  Mov Disord       Date:  2020-07-15       Impact factor: 10.338

8.  The sweet road to Parkinson's disease.

Authors:  Justine Renaud; Nicola Simola; Maria-Grazia Martinoli
Journal:  Aging (Albany NY)       Date:  2019-02-01       Impact factor: 5.682

9.  Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.

Authors:  Domenico Sergi; Justine Renaud; Nicola Simola; Maria-Grazia Martinoli
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

Review 10.  Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.

Authors:  Kai-Jung Lin; Tzu-Jou Wang; Shang-Der Chen; Kai-Lieh Lin; Chia-Wei Liou; Min-Yu Lan; Yao-Chung Chuang; Jiin-Haur Chuang; Pei-Wen Wang; Jong-Jer Lee; Feng-Sheng Wang; Hung-Yu Lin; Tsu-Kung Lin
Journal:  Antioxidants (Basel)       Date:  2021-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.